EDGAR Filing Documents for 0001193125-09-121628

Form 10-12B/A - Registration of securities [Section 12(b)]: [Amend]

SEC Accession No. 0001193125-09-121628

Filing Date

2009-05-29

Accepted

2009-05-29 16:58:29

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	AMENDMENT NO. 2 TO FORM 10	d1012ba.htm	10-12B/A	43499
2	FORM OF SEPARATION AND DISTRIBUTION AGREEMENT	dex21.htm	EX-2.1	178813
3	FORM OF AMENDED AND RESTATED CERTIFICATE OF INCORPORATION	dex31.htm	EX-3.1	30105
4	FORM OF AMENDED AND RESTATED BYLAWS	dex32.htm	EX-3.2	81925
5	FORM OF SUBLEASE AGREEMENT	dex101.htm	EX-10.1	192750
6	FORM OF TAX SHARING AGREEMENT	dex102.htm	EX-10.2	55040
7	FORM OF EMPLOYEE MATTERS AGREEMENT	dex103.htm	EX-10.3	83354
8	FORM OF INDEMNIFICATION AGREEMENT	dex108.htm	EX-10.8	33747
9	PRELIMINARY INFORMATION STATEMENT	dex991.htm	EX-99.1	1430621
11	GRAPHIC	g83276g36k53.jpg	GRAPHIC	14456
12	GRAPHIC	g83276g78e72.jpg	GRAPHIC	14062
13	GRAPHIC	g83276image_001.jpg	GRAPHIC	3889
14		filename14.htm	CORRESP	12955
	Complete submission text file	0001193125-09-121628.txt		2189334

Mailing Address 320 WAKARA WAY SALT LAKE CITY UT 84108

Business Address 320 WAKARA WAY SALT LAKE CITY UT 84108 801-584-3600

Myriad Pharmaceuticals, Inc. (Filer) CIK: 0001459450 (see all company filings)